Co-Authors
This is a "connection" page, showing publications co-authored by Emanuele Montomoli and Alessandro Manenti.
Connection Strength
2.831
-
The theory and practice of the viral dose in neutralization assay: Insights on SARS-CoV-2 "doublethink" effect. J Virol Methods. 2021 11; 297:114261.
Score: 0.962
-
Evaluation of SARS-CoV-2 neutralizing antibodies using a CPE-based colorimetric live virus micro-neutralization assay in human serum samples. J Med Virol. 2020 10; 92(10):2096-2104.
Score: 0.882
-
Serum Neutralizing Activity against B.1.1.7, B.1.351, and P.1 SARS-CoV-2 Variants of Concern in Hospitalized COVID-19 Patients. Viruses. 2021 07 12; 13(7).
Score: 0.239
-
Comparative analyses of SARS-CoV-2 binding (IgG, IgM, IgA) and neutralizing antibodies from human serum samples. J Immunol Methods. 2021 02; 489:112937.
Score: 0.229
-
Characterisation of SARS-CoV-2 Lentiviral Pseudotypes and Correlation between Pseudotype-Based Neutralisation Assays and Live Virus-Based Micro Neutralisation Assays. Viruses. 2020 09 10; 12(9).
Score: 0.226
-
SARS-CoV-2 escape from a highly neutralizing COVID-19 convalescent plasma. Proc Natl Acad Sci U S A. 2021 09 07; 118(36).
Score: 0.060
-
Characterization of antibody response in asymptomatic and symptomatic SARS-CoV-2 infection. PLoS One. 2021; 16(7):e0253977.
Score: 0.060
-
Detection of IgM, IgG and SARS-CoV-2 RNA among the personnel of the University of Milan, March through May 2020: the UNICORN study. BMJ Open. 2021 03 24; 11(3):e046800.
Score: 0.059
-
Extremely potent human monoclonal antibodies from COVID-19 convalescent patients. Cell. 2021 04 01; 184(7):1821-1835.e16.
Score: 0.058
-
Unexpected detection of SARS-CoV-2 antibodies in the prepandemic period in Italy. Tumori. 2021 Oct; 107(5):446-451.
Score: 0.057